The utility of rodent forestomach tumor data for hazard and risk assessment has been examined for decades because humans do not have a forestomach, and these tumors occur by varying modes of action (MOAs). We have used the MOA for ethyl acrylate (EA) to develop an Adverse Outcome Pathway (AOP) for forestomach tumors caused by non-genotoxic initiating events. These tumors occur secondary to site of contact induced epithelial cytotoxicity and regenerative repair-driven proliferation. For EA, the critical initiating event (IE) is epithelial cytotoxicity, and supporting key events (KEs) at the cellular and tissue level are increased cell proliferation (KE1) resulting in sustained hyperplasia (KE2), with the adverse outcome of forestomach papillomas and carcinomas. For EA, a pre-molecular initiating event (pre-MIE) of sustained glutathione depletion is probable. Supporting data from butylated hydroxyanisole (BHA) are also reviewed. Although there may be some variability in the pre-MIEs and IEs for BHA and EA, they share the same KEs, and evidence for BHA confers support for the AOP. Evolved Bradford Hill considerations of biological plausibility, essentiality, and empirical support were evaluated per OECD guidance. Although an MIE is not specifically described, overall confidence in the AOP is high due to well-developed and accepted evidence streams, and the AOP can be used for regulatory applications including hazard identification and risk assessment for chemicals that act by this AOP.
Introduction
At present, identification of the carcinogenic potential of environmental substances and pharmaceutical agents is largely based on 2-year chronic bioassays in rodent models. Given the time and cost involved, it is not possible to exhaustively test all chemicals to which humans might be exposed. In part for this reason, adverse outcome pathway (AOP) frameworks have been developed (Ankley et al., 2010; OECD, 2018; OECD, 2017) . In the most current guidance, the Organization for Economic Co-Operation and Development (OECD, 2017) states, "the AOP approach organises existing knowledge concerning biologically plausible and empirically supported links between molecular-level perturbation of a biological system and an adverse outcome (AO) at a level of biological organization of regulatory concern. This approach supports the use of a mode (and/or mechanism) of action basis for understanding the adverse effects of chemicals and other stressors." Although development of an AOP should be straightforward when building from a known MOA, the ability to predict human cancer hazard and risk from animal data is complicated by the diverse MOAs by which substances operate, and the typical conduct of animal cancer bioassays under exposure conditions that are not usually encountered by humans. For example, animal studies typically employ high dose exposures with the highest dose selected based on an identified maximum tolerated dose (MTD). An example adverse outcome that has been noted to be difficult to extrapolate to humans is forestomach tumors; an extrapolation question arising at least in part because humans do not possess a forestomach (Clayson et al., 1991; IARC, 2003; Kroes and Wester, 1986; Proctor et al., 2007 ). An AOP for forestomach tumors was started on the https://doi.org/10.1016/j.yrtph.2018.04.016 Received 17 February 2018; Received in revised form 15 April 2018; Accepted 18 April 2018 omach tumors has not been completed, and as such lacks important details.
The rodent forestomach is anatomically and functionally distinct from the glandular stomach and esophagus (de Zwart et al., 1999; Proctor et al., 2007; Wester and Kroes, 1988) . The proximal two-thirds of the rodent stomach chamber comprises the forestomach, which serves as an aglandular food reservoir lined by a cornified stratified squamous epithelium (see Supplemental Table S1 ). Food empties from the forestomach to the glandular stomach to meet energy demands (Uehara et al., 2018) . The forestomach and glandular stomach are separated by a limiting ridge; unlike the forestomach, the glandular stomach is lined by columnar epithelial cells along with glands that secrete mucus, gastric acid, and other hormones (e.g. gastrin). Under fed condition, the pH of the forestomach (∼4.8-5.1) is somewhat higher than that of the glandular stomach, which is ∼3.1-4.1 (Ward and Coates, 1987) . By comparison, the human stomach epithelium consists of columnar epithelial cells, with glands that secrete mucus and gastric acid. The pH of the human stomach varies from approximately 1 to 3.5 in fasted conditions and increases up to approximately 5.0 (interquartile range: 4.3 to 5.4) in fed conditions (de Zwart et al., 1999; Kararli, 1995) . The human esophagus consists of nonkeratinizing stratified squamous epithelium and submucosal glands secrete mucus to protect the epithelium. The human esophagus is very sensitive to acid, as evidenced by the condition referred to as reflux esophagitis where gastric acidity refluxes into the esophagus. This is commonly referred to as heartburn. Notably retention times for food or ingested toxicants in the human and rodent esophagus are negligible as compared to the rodent forestomach (Supplemental Table S1 ). For these reasons, the applicability of rodent forestomach tumors to human tissues/organs has been considered uncertain for some chemicals.
Challenges associated with using forestomach tumor data for hazard identification and risk assessment purposes have been addressed in several publications dating back at least three decades (Butterworth, 1989; IARC, 2003; Kroes and Wester, 1986; Proctor et al., 2007; Williams and Iatropoulos, 2009) , which speaks to the complexity of the issues, especially for non-genotoxic chemicals. In 2003, the International Agency for Research on Cancer (IARC) summarized the views and expert opinions of a working group in the publication, "Predictive Value of Rodent Forestomach and Gastric Neuroendocrine Tumors in Evaluating Carcinogenic Risks to Humans" (IARC, 2003) . The working group concluded, "If the exposure conditions are unusual (e.g., as with oral gavage dosing, which may result in high local concentrations of test substances in the forestomach for prolonged periods of time), the responses observed may be unique to the forestomach." However, the group also found that DNA-reactive chemicals that cause forestomach tumors should be evaluated for their potential to pose a carcinogenic hazard to humans. Indeed, this view is consistent with the notion that MOA analysis should be conducted for each tumor response to a carcinogen (U.S. EPA, 2005) . In this regard, a carcinogen might have a mutagenic MOA in one organ, but act via a threshold MOA in another organ (e.g. forestomach).
In 2007, Proctor and colleagues described a framework for evaluating the relevance of rodent forestomach tumors in cancer risk assessment (Proctor et al., 2007 Proctor et al. (2007) suggested a framework for assessing the human relevance of rodent forestomach tumors for cancer risk assessment that considered factors of genotoxicity, whether tumors were observed via gavage or other oral routes, and whether forestomach tumors occurred at doses that exceed the maximum tolerated dose (MTD) or cause irritation to the forestomach. Similar to the findings of IARC (2003), understanding chemical-specific toxicology and toxicokinetics was stressed.
Although forestomach tumors in rodents are expected to occur via various MOAs, chronic irritation-induced cytotoxicity by bolus gavage dosing is a common observation for many forestomach carcinogens (Ellis-Hutchings et al., 2018; Proctor et al., 2007; Wester and Kroes, 1988) . Importantly, gavage dosing per se does not promote forestomach tumors, but rather bolus gavage dosing can result in dose rates of exposure that are unlikely to recapitulate typical environmental exposure. Proliferative lesions in the forestomach, resulting from a combination of factors related to route-and rate-specific tissue irritation, may be of limited relevance for assessing human carcinogenic potential. This is especially true for agents that cause tumors exclusively in the forestomach because one characteristic of genotoxic carcinogens is that they tend to cause tumors in multiple organs (Proctor et al., 2007) . The majority of studies on the induction of rodent forestomach neoplasia stress that chronic, sustained hyperplasia is a major influential/essential characteristic, particularly for non-genotoxic agents (Grasso et al., 1991; IARC, 2003; Kroes and Wester, 1986; Williams and Iatropoulos, 1996) . Indeed, it has been posited that human exposure to non-genotoxic chemicals at concentrations below a level that results in irritation does not pose a cancer hazard (Clayson et al., 1991; Wester and Kroes, 1988) . This view is supported by an expert panel of the Flavor Extract Manufacturer's Association (Adams et al., 2008) .
To facilitate the risk assessment and human relevance understanding of forestomach tumors, herein we apply chemical-specific MOA information in an AOP framework to develop a more general model of forestomach cancer. The OECD describes several important uses for AOP (OECD, 2017) . Well defined AOPs with strong evidence for key event relationships can improve quantitative dose-response analysis for risk assessment (e.g. biologically based dose-response models). AOPs can organize data and better inform data gaps in our general understanding of the adverse outcome, in much the same way that MOA analysis can identify data gaps in for specific chemical-induced adverse effects. AOPs can help prioritize assay development for identifying key events (including the MIE). Herein, an AOP for forestomach tumors induced by non-genotoxic mechanisms is proposed. The objectives of developing an AOP for rodent forestomach are to: (1) describe the important conditions for the IE to take place, and the IE itself, which drives subsequent key events (KEs) in the tumorigenesis process for chemicals that act by this pathway; (2) set the stage for development of an AOP network for forestomach cancer that might arise from different KEs, (3) act as a tool for the understanding human relevance of certain AOPs within an expanded AOP network; and (4) provide insights regarding hazard identification and risk assessment approaches for chemicals within this AOP and within an expanded AOP network.
Approach for forestomach AOP development
The proposed cytotoxic forestomach tumor AOP (Fig. 1) (Ankley et al., 2010; OECD, 2018) . In 2013, Becker and colleagues introduced the term 'initial molecular interaction' (IME) as an upstream step in an AOP (Patlewicz et al., 2013) . In 2015, Becker and colleagues indicated that IME was synonymous with the concept of a 'pre-MIE' (Becker et al., 2015a) . Both terms are proposed to distinguish a molecular 'interaction' from an adverse molecular 'event'. An example AOP for aryl hydrocarbon receptor (AhR)-mediated liver tumor formation lists binding to the AhR as a pre-MIE and sustained activation of the AhR as the MIE (Becker et al., 2015b ). As will be described below, there is significant data indicating that bolus administration of ethyl acrylate acutely binds and depletes low molecular weight thiols such as GSH, as well as binds to proteins within the forestomach (see Thompson et al., 2018) . It is probable that this2018ding contributes to the cytotoxic response that leads to epithelial cytotoxicity. As such, binding to GSH and/or proteins might be considered a pre-MIE (or IME), whereas as repeated binding and depletion could be considered the MIE. To date, however, strong counterfactual evidence for the necessity of thiol binding and depletion is lacking and thus cannot be confidently established as the MIE leading to cytotoxicity. Nevertheless, we have chosen to include GSH and protein binding as a possible 'pre-MIE'.
Epithelial cytotoxicity is more fully supported as the MIE. Indeed, others have considered cytotoxicity as a MIE in an AOP for intestinal cancer (Becker et al., 2015a) . While there is precedent for cytotoxicity serving as the MIE (Becker et al., 2015a) , AOP Wiki 1 ), we do not agree that such an event at the cellular level is consistent with the spirit of the molecular initiating event (i.e. MIE) terminology (Ankley et al., 2010; OECD, 2017) . Therefore, we consider cytotoxicity to be better characterized as the initiating event (IE), as the cellular level of organization is higher than the macromolecular level. In addition to clarifying nomenclature, considering cytotoxicity as the IE allows for a broader presentation of non-genotoxic forestomach carcinogens such as butylated hydroxyanisole (BHA). Because AOPs are meant to be 'living' or evolving representations (OECD, 2017) , future research may fully support identification of a well described MIE such as sustained/repeated protein and/or GSH binding leading to cytotoxicity as an MIE.
2.1. MOA for ethyl acrylate Thompson et al. (2018) recently conducted a formal MOA analysis for forestomach tumors induced by ethyl acrylate, concluding that the weight of evidence supports a cytotoxic, threshold MOA. The key events of this MOA are: (1) bolus dose to the forestomach lumen, and subsequent absorption; (2) cytotoxicity to the forestomach due to saturation of metabolism detoxification pathways; (3) chronic regenerative hyperplasia; and (4) spontaneous mutation resulting from increased cell proliferation. This finding is consistent with conclusions reached by the National Toxicology Program (NTP), which delisted ethyl acrylate as "reasonably anticipated to be carcinogenic to humans" based on "the fact that the forestomach tumors induced in animal studies were seen only when the chemical was administered by gavage at high concentrations … that induced marked local irritation and cellular proliferation and because significant chronic human exposure to high concentrations of ethyl acrylate monomer is unlikely" (NTP, 2000; NTP, 2004 ).
An important element in the more recent MOA analysis is that recent transgenic rodent (TGR) in vivo mutation assay was conducted in gpt delta mice to provide further support for MOA (Ellis-Hutchings et al., 2018) . Using OECD Test Guideline 488 (OECD, 2013) methods, Ellis-Hutchings et al. (2018) exposed mice to ≤50 mg/kg ethyl acrylate in corn oil for 28 days, followed by a 3-day recovery/fixation period. The high dose level (50 mg/kg) is within the initial saturated range for ethyl acrylate metabolism by GSH, and was selected to avoid a potentially confounding mutagenic response by inflammation (EllisHutchings et al., 2018) . No significant changes in mutant frequency (MF) in stomach epithelium, which includes the forestomach, were observed at any dose. This was consistent with the general lack of positive in vivo or in vitro mutagenic responses for ethyl acrylate (see Thompson et al. (2018) for detailed discussion).
2.2. Summary of ethyl acrylate data supporting a cytotoxic AOP for forestomach tumors 2.2.1. Evidence for a pre-molecular initiation event (pre-MIE) (molecular level)
For the forestomach tumor AOP, using ethyl acrylate evidence as a case-study, the weight of evidence supports a finding that the pre-MIE events result from interaction with low and high molecular weight thiols such as GSH and proteins (Thompson et al., 2018) . The toxicity of ethyl acrylate is believed to be related to the ester linkage and the unsaturated double bond. In vitro binding assays indicated that α,β-unsaturated acrylic esters, including ethyl acrylate readily bind with the sulfhydryl group of cysteine but bind with less affinity to the amine group of glycine (Friedman et al., 1965) . Non-enzymatic conjugation of ethyl acrylate with GSH, a tripeptide that includes a cysteine, has been demonstrated in vitro (Potter and Tran, 1992) . A second-order rate constant of 20-30 M −1 min ¬1 has been calculated (Hashimoto and Aldridge, 1970; McCarthy et al., 1994; Potter and Tran, 1992) , and binding of ethyl acrylate with protein in various tissues was demonstrated to have rate constants similar to those for GSH, indicating preferential binding to cysteine thiols (Potter and Tran, 1992) . Bolus oral exposure (single or repeated) to ethyl acrylate leads to depletion in GSH in the forestomach, with conjugation depletion reported to occur at concentrations between 10 and 20 mg/kg (Ellis-Hutchings et al., 2018; Frederick et al., 1990) . GSH depletion has been shown to impair cellular protective mechanisms, which is directly related to increased cytotoxicity (Lushchak, 2012) , the proposed IE in forestomach tumorigenesis.
Initiating event (IE) (cellular level)
In the case of ethyl acrylate, lesions occur in the forestomach following oral gavage administration, indicative of cytotoxicity. Rats administered a single oral gavage dose of 100-400 mg/kg of ethyl acrylate exhibited mucosal and submucosal edema, submucosal inflammation, erosion, and ulceration of the squamous epithelium of the forestomach, which were shown to occur in a dose-and time-dependent manner (Ghanayem et al., 1985a) . Edema of the mucosa and submucosa, as well as vacuolization of the tunica muscularis (the muscular layer adjacent to the submucosa) in the forestomach, was observed within 4 h following administration in 100% (8/8) of male F344 rats administered a single oral gavage dose of 2 mmol/kg ethyl acrylate [∼200 mg/kg] (Ghanayem et al., 1985b ). In rats treated with 100 mg/kg, the incidence of mucosa or submucosal edema and vacuolization in these forestomach Fig. 1 . Schematic of the epithelial cytotoxicity rodent forestomach tumor AOP with ethyl acrylate as a case example.
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Regulatory Toxicology and Pharmacology 96 (2018) 30-40 locations was only slightly lower (7/8, 6/8, and 3/8 animals, respectively) (Ghanayem et al., 1985a) . In another study, necrosis, vesiculation (the formation of vesicles), and acute inflammation were observed in the forestomach epithelium within 20-36 h following administration by oral gavage of 200 mg/kg ethyl acrylate to male F344 rats (Gillette and Frederick, 1993) . Two-week repeated dose exposures generally showed a similar response with edema and inflammation being apparent at levels ≥100 mg/kg/day (Frederick et al., 1990) . It should be noted that erosion, ulceration, vacuolization and edema are not necessarily key events in the AOP but can be indicative of acute bolus toxicity (prior to adaptation) or present after long-term exposure. For example, forestomach ulceration was observed at lower incidence than hyperplasia and hyperkeratosis in the 2-year bioassay for ethyl acrylate (NTP, 1986) . As such, ulceration is not a necessary antecedent to hyperplasia, as regenerative proliferation can occur with milder forms of cytotoxicity such as superficial erosion.
KE #1: Increase in Regenerative Proliferation of Forestomach Epithelial Cells (cellular level).
Cytotoxic doses of chemical agents, whether genotoxic or nongenotoxic, leads to cell death, which subsequently stimulates a regenerative-repair cell proliferative response (Schulte-Hermann et al., 1999) . While an increase in cell proliferation and/or survival induced by a chemical may not necessarily lead to cancer, chronic cellular regeneration from chronic tissue injury, increases the opportunity for spontaneous mutations to accumulate in the epithelial cells with clonal expansion of spontaneously arising, initiated foci that would otherwise be eliminated via apoptosis. This is a well-accepted risk factor for carcinogenesis (Ames et al., 1993; Boobis et al., 2009; Cohen and Ellwein, 1990; Cohen and Ellwein, 1991; Greenfield et al., 1984) . Gillette and Frederick (1993) conducted a series of experiments to evaluate epithelial cell proliferation by measuring S-phase response (via pulse measurements with 5-bromodeoxyuridine [BrdU] labeling) in the forestomach and glandular stomach of male F344 rats following singleand multiple-dose exposures to ethyl acrylate by gavage dosing in corn oil (See Table 1 for experimental details and results). In acute dosing experiments, carcinogenic doses of ethyl acrylate induce increased forestomach proliferation as early as 10 h after commencement of treatment (Table 1) . Another acute-dosing experiment demonstrated dose-dependent increases in S-phase activity 24-hr after dosing, with a significant elevation of S-phase nuclei at doses ≥20 mg/kg (Table 1) . However, repeated dosing studies reported increases in S-phase cells only at 200 mg/kg (Table 1) .
Although morphological changes associated with cytotoxicity were noted only in the 200-mg/kg dose group, the authors indicated that cytotoxicity at lower doses may have interfered with measures of Sphase activity. Thus, it is likely that more subtle cytotoxicity occurred in the lower dose groups as well. This study demonstrates proliferation at doses as low as 20 mg/kg ethyl acrylate after a single gavage dose. Based on the findings of the multiple-dose gavage study (Table 1) , Gillette and Frederick (1993) opined that the lack of effects at lower doses was due to an ability to significantly increase detoxification potential in response to multiple exposures. With the current recognition that thiol interaction is likely pre-MIE, it is likely that sustained dosing resulted in upregulation of GSH production in the epithelium in the animals that were dosed for two weeks.
KE #2: hyperplasia (tissue level)
A sustained increase in cellular proliferation results in the development of hyperplasia, a tissue-level KE. Hyperplasia itself is not synonymous with neoplasia, nor is it necessarily indicative of pre-neoplastic lesions (Greaves, 2012; Kooistra and Nyska, 2014) . In fact, forestomach hyperplasia induced by EA can be reversible (see below). Nevertheless, sustained hyperplasia could cause tumor promotion by increasing spontaneous mutations as well as facilitating clonal expansion of initiated cells (Porth and Porth, 2011) . Hyperplasia can be Table 1 Summary of Gillette and Frederick (1993) * Although morphological changes associated with cytotoxicity were noted only in the 200-mg/kg dose group, Gillette and Frederick (1993) noted that cytotoxicity at lower doses may be interfered with measures of Sphase activity.
∇ Gillette and Frederick (1993) opined that lack of effects at lower doses were due to an ability to significantly increase detoxification potential in response to repeated (multiple) exposures. D.M. Proctor et al. Regulatory Toxicology and Pharmacology 96 (2018) 30-40 considered a pre-neoplastic lesion leading to papillomas and carcinomas in the forestomach epithelium, and is associated with various stimuli, particularly chemical insults (Clayson et al., 1991) . Hyperplasia was observed in several studies of ethyl acrylate (Frederick et al., 1990; Ghanayem et al., 1985a; Ghanayem et al., 1986; Ghanayem et al., 1991b; Ghanayem et al., 1993; Gillette and Frederick, 1993; NTP, 1986) . Ghanayem et al. (1985b) examined male F344 rats 24 h after a single gavage dose of 200 mg/kg ethyl acrylate; forestomach hyperplasia was not evident (n = 8 rats). With two and four consecutive daily gavage doses of 200 mg/kg, ethyl acrylate induced forestomach hyperplasia in all rats examined (n = 8 per treatment group). This study showed that forestomach hyperplasia was evident as early as two days after treatment (Ghanayem et al., 1985b) . Frederick et al. (1990) demonstrated that repeated dose oral bolus exposures to ethyl acrylate for two weeks (2, 10, 20, 50, 100, or 200 mg/kg/day; 5 days/week) in male F344 rats resulted in epithelial hyperplasia and hyperkeratosis as low as 20 mg/kg/day with a dosedependent increase in the incidence and severity at higher dose levels. Ghanayem et al. (1985a) similarly showed that doses of 100 and 200 mg/kg by oral gavage, 5 days/week for 2 weeks, induced a dramatic increase (12/12 rats in both dose groups) in mucosal hyperplasia of the forestomach 24 h following the last dose. Hyperplasia was a persistent effect following administration of 200 mg/kg, but not 100 mg/kg, ethyl acrylate, even after cessation of treatment. After 1 week of recovery, 6/8 and 8/8 rats exhibited hyperplasia in the 100-mg/kg and 200-mg/kg dose groups, respectively. After 2 weeks of recovery, 0/8 and 8/8 rats exhibited hyperplasia in the 100-mg/kg and 200-mg/kg groups, respectively. After 4 weeks of recovery, hyperplasia was still evident in all 8 rats that were exposed to 200 mg/kg. Ghanayem et al. (1991a) conducted another reversibility study in F344 rats exposed to 100 and 200 mg/kg ethyl acrylate for 13 weeks via corn oil gavage. Immediately following 13 weeks of exposure, 100% of the exposed rats exhibited forestomach hyperplasia. After 8 weeks of recovery, 1/10 and 6/10 exhibited hyperplasia in the 100-and 200-mg/ kg groups, respectively. After 19 months of recovery, hyperplasia was evident in rats in 6%, 8%, and 31% of control, 100-mg/kg, and 200-mg/kg dosed rats, respectively (Ghanayem et al., 1991b) .
In a study that demonstrated a link between hyperplasia and tumors, F344 rats were administered 200 mg/kg ethyl acrylate for 6 or 12 months and allowed to recover (Ghanayem et al., 1993) . Although there were no neoplastic changes at 6 or 12 months of exposure to ethyl acrylate, mucosal hyperplasia was observed in all administered rats. In rats that were allowed to recover for 15 months following 6 months of ethyl acrylate administration, no hyperplasia or tumors were detected. However, in 13 rats administered ethyl acrylate for 12 months and allowed to recover for an additional 9 months, mucosal hyperplasia was observed in 8 rats, and 4 rats had forestomach tumors. These data support the link between sustained hyperplasia with continued administration of ethyl acrylate and tumor development.
Moreover, hyperplasia of the epithelium was observed in the forestomach of B6C3F1 mice administered ethyl acrylate via oral gavage in a 2-year cancer bioassay (NTP, 1986). The incidence of hyperplasia was higher in the high-dose group in both species (26/50 male and 30/ 50 female mice, and 46/50 male 49/50 female rats, at 200 mg/kg) relative to the lower dose (17/50 male and 12/50 female mice, 41/50 male and 34/50 female rats, at 100 mg/kg) (Fig. 2) and was typically accompanied by hyperkeratosis in both species. It is important to note that hyperplasia occurred consistently at much higher rates in all four groups of animals tested, as compared to papillomas and carcinomas (Fig. 2) , supporting the consideration of chronic hyperplasia as a key event in the AOP for cytotoxicity-induced forestomach tumors. Finally, it is interesting that Gillette and Frederick (1993) remarked on structural changes in the forestomach mucosa. Specifically, after two weeks of exposure to 200 mg/kg ethyl acrylate, the basement membrane (but not the muscularis mucosa) became folded. This change, observed at 2 weeks of exposure, is unlikely related to dysregulated cell growth or transformation, but rather may be an adaptive response to chronic irritation.
A third key event for spontaneous mutation was considered; however, key events in an AOP framework are ideally measurable. Spontaneous mutation resulting from chronic increased cell proliferation during hyperplasia is likely a rare event and therefore unlikely amenable to measure apart from tumor formation. Nevertheless, there is likely a key event relationship linking the probability of spontaneous mutation to estimates of the number of cells replicating in the forestomach over a certain duration of time. Similarly, there is also likely a key event relationship between the number of spontaneous mutations and the likelihood that such mutations result in the adverse outcome of forestomach tumors. These key events and key event relationships might be added to this AOP in the future as more data become available.
Adverse outcome
Forestomach tumors are of regulatory significance because they are used for hazard identification and risk assessment (IARC, 2003; Proctor et al., 2007) . High dose levels of ethyl acrylate cause a dose-dependent increase in forestomach tumors in rats and mice of both sexes following chronic oral gavage administration (Fig. 2) (NTP, 1986 ). In the twoyear NTP bioassay, the incidences of papilloma and carcinoma were considerably lower than those of chronic hyperplasia (Fig. 2) , supporting a conclusion that the AO (forestomach tumors) is downstream of hyperplasia (KE2) in the AOP.
Other forestomach carcinogens that support the proposed AOP
To establish additional evidence to support the proposed AOP, several forestomach carcinogens were reviewed for evidence of concordance with the IE and KEs detailed herein for forestomach tumors induced by gavage dosing with ethyl acrylate. Example chemicals were identified based on searching the NTP databases, as well as the IARC (2003) and Proctor et al. (2007) reviews. Searches were conducted based on the criterion that the chemical caused forestomach tumors in rodents following oral administration and not by other routes. Although many chemicals cause forestomach tumors, the literature available to review potential KEs is limited for most. However, data on butylated hydroxyanisole (BHA), a phenolic compound, support similar key events as ethyl acrylate (Ito et al., 1993; Whysner and Williams, 1996) .
Summary review for butylated hydroxyanisole (BHA)
BHA is an antioxidant that induces squamous-cell carcinomas in the forestomach of rats and mice, but not the glandular stomach or other organs (Hirose et al., 1990; Hirose et al., 1998; Tamano et al., 1992) . BHA is a synthetic antioxidant used to preserve foods, particularly oils, fats, and shortenings (European Food Safety Authority (EFSA, 2011; NAS, 1996; Verhagen et al., 1991) . Although BHA induced forestomach tumors, it has also been shown to inhibit carcinogenesis in animals (Ito and Hirose, 1989) . BHA is a mixture of two isomers-2-tert-butyl-4-hydroxyanisole (2-BHA) and 3-tert-butyl-4-hydroxyanisole (3-BHA) (EFSA, 2011) .
Similar to ethyl acrylate, BHA induces cytotoxicity, including ulceration and necrosis of the forestomach and hyperplasia. Several review articles and texts indicate that while the exact mechanism of BHA carcinogenicity remains uncertain, there is strong evidence for cytotoxicity and hyperplasia leading to carcinogenicity (Greaves, 2012; Whysner and Williams, 1996) . Dietary BHA administration induces forestomach squamous-cell papillomas and carcinomas in male Sprague Dawley rats, male Syrian golden hamsters, and male B6C3F1 mice (Ito et al., 1983; Ito et al., 1985; Ito and Hirose, 1989; Masui et al., 1986) . BHA might share a similar pre-MIE as ethyl acrylate, as it has been suggested that the cytotoxicity of BHA might be mediated through GSH and/or protein binding. As has been shown for ethyl acrylate (Ghanayem et al., 1991a) , co-treatment with the GSH depleting agent D.M. Proctor et al. Regulatory Toxicology and Pharmacology 96 (2018) 30-40 DEM protects against BHA-induced cell proliferation (Shibata et al., 1993) . This is posited to be due to evidence that DEM increases GSH in the forestomach, whereas it decreases GSH in other tissues. As such, increasing forestomach GSH with DEM mitigates the toxicity for both BHA and ethyl acrylate, possibly by limiting covalent protein binding or mitigating oxidative stress resulting from GSH depletion. In Cantoreggi et al. (1993) , male F344 rats were administered 0.5%, 1%, or 2% BHA in diet (in groups of five) for 4 weeks, to serve as positive controls to rats treated with styrene 7,8-oxide. Before termination, all rats were implanted with BrdU using an osmotic minipump, and cellular proliferation in three different anatomical regions of the forestomach was evaluated by immunohistochemistry for BrdU incorporated into DNA. For all BHA dose groups, significant increases in the labeling index were reported in all regions of the forestomach; additionally, morphological changes were observed with increases in the number and size of hyperplastic lesions. In rats treated with 0.5% BHA, mild hyperkeratinization and increased thickness of the squamous epithelial layer was reported; mild hyperplastic lesions near the limiting ridge were reported for one animal. In all animals treated with 1% BHA, squamous epithelial hyperplasia and hyperkeratosis near the limiting ridge were observed, while few animals had hyperplastic lesions in the midregion of the forestomach. In the 2% BHA dose group, hyperplasia of varying degrees was observed in all animals, and one possible case of papilloma near the limiting ridge of the forestomach was noted. Mild hyperplastic lesions were observed in the midregion of the forestomach for three animals. The study investigators indicated that BHA followed the characterization of forestomach carcinogenesis by Takahashi and Hasegawa (1990) , in which sequential development of epithelial tumors in the rodent forestomach was described as starting with epithelial damage, proceeding to hyperplasia and other tissue damage (e.g., hyperkeratosis, dysplasia), and then to development of papillomas and squamous-cell carcinoma (Cantoreggi et al., 1993; Takahashi and Hasegawa, 1990) . This sequential development, described before the concepts of MOA and AOP were formalized, bears considerable consistency with the AOP developed here using the data for ethyl acrylate.
Similar to ethyl acrylate, reversibility of forestomach lesions was observed in recovery studies of BHA (Ito et al., 1993; Kagawa et al., 1993) . Kagawa et al. (1993) treated groups of 31 male F344 rats with 2% BHA in diet for 24 weeks. Ten animals were terminated at Week 24; half of the remaining animals were maintained on basal diet alone for an additional 24 weeks, and the other half continued to receive the compounds in diet and were then terminated at Week 48. This study included groups dosed with four genotoxic carcinogens, including Nmethylnitrosourea, as positive controls. In rats that received BHA for 24 weeks, severe papillary hyperplasia was observed in 100% of animals. After cessation of treatment for 24 days, severe papillary hyperplasia was not observed in either treatment group (Kagawa et al., 1993) . Observations were similar for like treatments in the Ito et al. (1993) study. However, in both of these studies, treatment with genotoxic carcinogens demonstrated no regression after cessation of dosing. Kagawa et al. (1993) also reported "atypical" hyperplasia (defined by the authors as areas of hyperplasia consisting of basal cell-like atypical cells with large nuclei and prominent nuclei with loss of polarity in their arrangement) was observed at a high incidence rate among rats receiving genotoxic carcinogens, but not with 48 weeks of continuous administration of BHA (Kagawa et al., 1993) .
Overall, databases for BHA and ethyl acrylate are remarkably similar. Both are generally negative in genotoxicity assays, both demonstrate cell proliferation at the cellular and tissue level, and both are reversible ( Table 2 ). As such, the MOAs for BHA and ethyl acrylate are likely similar and are represented by the AOP presented in Fig. 1 . Furthermore, data indicate that BHA and ethyl acrylate may share the same pre-MIE. Fig. 2 . Incidence of hyperplasia, inflammation, and neoplastic lesions in rats and mice in a 2-year cancer bioassay (NTP, 1986).
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Regulatory Toxicology and Pharmacology 96 (2018) 30-40 Table 2 Evidence in support of the proposed AOP. Significant increase in the rate of cell proliferation in all three anatomical regions of the forestomach among rats administered 0.5%-2% BHA in diet for 4
weeks (Cantoreggi et al., 1993) Dose-dependent increase in hyperplasia observed among rats exposed to 0.5%-2% BHA in diet for 4 weeks (Cantoreggi et al., 1993) Squamous-cell papillomas and carcinomas in rats, hamsters, and mice (Hirose et al., 1998; Ito et al., 1983; Ito et al., 1985; Ito and Hirose, 1989; Masui et al., 1986) Ethyl Acrylate (140-88-5) No mutagenic response in bacterial mutation assays (Zeiger et al., 1992) , in vivo micronucleus assays (Ashby et al., 1989) , or in vivo transgenic rodent model (Ellis-Hutchings et al., 2018) .
Regenerative hyperplasia and hyperkeratosis are typical responses to mucosal injury. Bolus doses induce edema, erosion, and ulceration. Increase in BrdU labeling observed in forestomach epithelium at ≥20 mg/kg 24 h after single acute exposure, and at ≥200 mg/kg following two weeks of repeated exposure (Gillette and Frederick, 1993) Dose-dependent increase in hyperplasia observed among rats and mice in numerous studies (Frederick et al., 1990; Ghanayem et al., 1985a; Ghanayem et al., 1991a; Ghanayem et al., 1993; NTP, 1986) Squamous-cell papillomas and carcinomas in rats and mice (Ghanayem et al., 1993; NTP, 1986) 
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Scientific confidence in the AOP
The evolved Bradford Hill considerations of biological plausibility, essentiality, and empirical support of KE responses are recommended for evaluation of the confidence in a given AOP (OECD, 2018; OECD, 2017) , and weight-of-evidence considerations have been proposed for describing the level of confidence in the AOP (Becker et al., 2015a) . These criteria were used to assess the AOP described herein for forestomach tumors induced by non-genotoxic mechanisms.
Biological plausibility
For biological plausibility, the defining question is whether a mechanistic relationship exists between upstream and downstream KEs, consistent with established biological knowledge (Becker et al., 2015a) . For the proposed AOP, the evidence for biological plausibility is considered "high." Regenerative hyperplasia is well-known for increasing tumor risk (Ames et al., 1993; Boobis et al., 2009; Cohen and Ellwein, 1990; Cohen and Ellwein, 1991; Greenfield et al., 1984; Meek et al., 2003; U.S. EPA, 2005) . Thus, as defined by OECD (2017) guidance, the broad acceptance of the mechanistic basis for this AOP results in a high degree of confidence that the proposed AOP is biologically plausible. Ghanayem et al. (1993) demonstrated that prolonged hyperplasia by gavage administration of ethyl acrylate for 12 months was required to induce tumors. Further, other researchers have reached similar conclusions regarding the MOA for ethyl acrylate-induced forestomach tumors (Ellis-Hutchings et al., 2018; Thompson et al., 2018; Williams and Iatropoulos, 2009) . Also, it is notable that several published studies (Clayson et al., 1991; Ito et al., 1993; Kagawa et al., 1993) as well as the IARC (2003) Technical Publication conclude that phenolic compounds, including BHA and sesamol, act by a pathway involving cytotoxicity induced hyperplasia, and that prolonged hyperplasia results in tumor formation. Thus, broad consensus adds strength to the biological plausibility of the proposed AOP.
Support for essentiality of KEs
The defining question presented in the OECD (2017) guidance for evaluation of essentiality is, "[A]re downstream KEs and/or the AO prevented if an upstream KE is blocked?" The database of recovery studies for ethyl acrylate-and BHA-induced hyperplasia is relatively robust, and the studies consistently demonstrate reversibility (Ghanayem et al., 1985b; Ghanayem et al., 1991b; Ghanayem et al., 1993; Ito et al., 1993; Kagawa et al., 1993) . Thus, as defined by Becker et al. (2015a) , confidence in the essentiality is also high.
As mentioned previously, the essentiality of GSH depletion and/or protein binding has not been directly established as the MIE with counterfactual studies. Future studies may allow for a specific MIE involving disruption of cellular thiols. Similarly, inflammation was not included as a KE because the incidence of inflammation was similar with, or notably lower than, that for hyperplasia and tumor formation in the NTP (1986) bioassay for ethyl acrylate (Fig. 2) , and it is not clear that preventing inflammation would prevent tumor formation. Nonetheless, acute inflammation has been noted in response to bolus doses of ethyl acrylate (Bernacki et al., 1987b; Frederick et al., 1990; Ghanayem et al., 1985a; Gillette and Frederick, 1993) . Tissue injury elicits inflammatory response, and we view the inflammatory response as part of the cytotoxic response.
Empirical evidence
In line with the Bradford-Hill criteria for causal relationships, the guidance for evaluating empirical evidence of an AOP focuses on doseresponse and temporal concordance of key events (OECD, 2018; OECD, 2017) . Using ethyl acrylate administration by oral gavage to rats as an example, a dose-response and temporality table was constructed (Table 3 ). The template for this table is included in the OECD AOP guidance, and is a requirement of the human relevance MOA framework. The data indicate a relatively narrow dose window for the reduction of GSH-three hours at a single dose ≥20 mg/kg (EllisHutchings et al., 2018) . The induction of cytotoxicity and cell proliferation occurred at ≥20 mg/kg following single-dose exposure (Gillette and Frederick, 1993) ; hyperplasia was observed in animals dosed with 20-200 mg/kg for 2-13 weeks (Frederick et al., 1990; Ghanayem et al., 1991b) , and carcinogenicity occurred at 100 and 200 mg/kg following 12 months to 2 years of gavage dosing (Ghanayem et al., 1994; NTP, 1986) (Table 3 ). This dose-concordance and temporality pattern is consistent with a threshold response for cellular toxicity and repair, which is associated with prolonged depletion of GSH (Ellis-Hutchings et al., 2018; Williams and Iatropoulos, 2009 ). Hyperplasia and tumor incidence were both higher in rats and mice treated with ethyl acrylate, indicating that there is a dose-response concordance between species. Although the body of data describing temporal and dose-dependent trends for cytotoxicity is limited, the overall evidence supports a logical progression of effects with dose and time and provides sufficient empirical evidence for the AOP. For a more detailed discussion of the empirical evidence as it relates to ethyl acrylate, see Thompson et al. (2018) .
Overall, confidence in the empirical evidence can be described as moderate, consistent with the outline of Becker et al. (2015a) . The defining question is whether the empirical evidence supports that a change in an upstream KE leads to an appropriate change in a downstream KE (Becker et al., 2015a) . The relative level of confidence in this case, is determined to be moderate-based on the categorization described by Becker et al. (2015a) : "a demonstrated dependent change in both effects following exposure to a small number of specific stressors and some evidence that is inconsistent with expected pattern …" Our review of the literature indicates that only a relatively small number of forestomach carcinogens are recognized/accepted to induce tumors via non-genotoxic mechanisms and are limited to this tissue site. These tend to be non-genotoxic agents that are carcinogenic by gavage dosing-possibly because the lack of genotoxicity and bolus dosing lend themselves to relatively straightforward (and 'low risk') MOA determinations. For ethyl acrylate and BHA, the pattern of key events is reasonably clear and well-supported quantitatively (Tables 2 and 3 ).
Considerations for species specificity and human relevance
Species-specific effects of various toxicants are known, and can be attributable to differences in metabolism, genetics, or tissue/organ structure and function (Anderson, 1998; de Zwart et al., 1999; Martignoni et al., 2006 ). An obvious example is tumorigenicity in tissues that are present only in animal models. The MOA for ethyl acrylate and the other example chemicals assessed herein is specific to the rodent forestomach and occurs as a result of non-genotoxic mechanisms at high doses. These chemicals have not been shown to cause tumors in other organs, including the glandular stomach. For ethyl acrylate, a high dose rate (i.e. repeated bolus gavage dosing) is an important factor in forestomach tumor formation, as no tumors were observed in the forestomach nor any other tissue following chronic administration of carcinogenic doses by drinking water (Bernacki et al., 1987a) , by inhalation (Miller et al., 1985; Treon et al., 1949) , or by the dermal route (DePass et al., 1984; Nylander-French and French, 1998) . The lack of evidence for mutagenicity (Ellis-Hutchings et al., 2018) , and lack of tumors in other organs following oral gavage and other routes of exposure, clearly support the lack of human relevance of the non-genotoxic forestomach tumor AOP described herein. Similar conclusions have been reached for BHA and sesamol (Clayson et al., 1991; Ito et al., 1993) .
The organ specificity of ethyl acrylate and other forestomach carcinogens is notable. Data indicate that forestomach tumors are the sixth most common tumor site in NTP rodent 2-year cancer bioassays, D.M. Proctor et al. Regulatory Toxicology and Pharmacology 96 (2018) 30-40 (Chandra et al., 2010) . This specificity indicates that forestomach tumors in rodents are likely the result of organ specific differences between the forestomach and glandular stomach. For example, in contrast to the glandular stomach, the long retention time, absence of mucus secreting glands, and higher pH of the forestomach may facilitate carcinogenesis. Thus, the absence of a forestomach in humans implies that forestomach tumors are not relevant to humans; moreover, the lack of carcinogenicity in the rodent glandular stomach should be viewed similarly to any other organ that fails to develop tumors in a chronic bioassay. Although the human esophagus shares some characteristics with the rodent forestomach (e.g. stratified squamous epithelium) (IARC, 2003) , the tissue dose to the forestomach epithelium differs from that to the oral cavity and esophagus due to the longer retention time (Kroes and Wester, 1986) . A more complete discussion of the functional and anatomical differences between the rodent forestomach, human esophagus and human stomach is presented in Proctor et al. (2007) .
Finally, it is important to consider that tumors induced by chronic irritation occur at doses that are generally considered to exceed the MTD. A kinetically-derived MTD is considered a dose at which metabolism is saturated (absorption, metabolism, or excretion) and normal repair mechanisms would be overwhelmed (Dorato et al., 2008) . The relevance of any carcinogenic response in animals at the MTD and/or at doses that overwhelm protective mechanisms for assessing human risk is questionable and has been the subject of much debate (NAS, 1993) . As such, the tissue doses at which these tumors occur is not consistent with that which would occur in human exposure scenarios, and therefore the human relevance of tumors occurring by this AOP is limited.
Conclusions
There are several potential applications of AOPs, including but not limited to: integrated approaches for testing and assessment (IATA), development or refinement of test methods (including OECD guidelines), hazard classification-such as Globally Harmonized System (GHS), categorization and read-across, and risk assessment (OECD, 2018; OECD, 2017) . OECD (2017) guidance states that "AOPs will exist along a continuum between putative, completely qualitative and completely quantitative. It is important to note that an AOP is never complete-it can continue to evolve, but that does not preclude its use to support decision-making."
Regarding this AOP for forestomach tumors, the available data are sufficient to support an initiating event of cytotoxicity, leading to regenerative proliferation, hyperplasia and ultimately tumor formation by expansion of spontaneous mutations. For both ethyl acrylate and BHA, these key events appear to be facilitated by the loss of intracellular thiols (GSH) and altered protein shape and function produced by formation of protein disulfides.
Consistent with the goals of any AOP, this AOP can also be used to inform decisions regarding hazard identification and characterization. Although this AOP, quite unconventionally, does not include a single MIE, and multiple IEs and pre-IEs are considered possible and/or likely, it is reasonable to conclude that forestomach tumors induced by these non-genotoxic events are not relevant to human cancer risk. This is because the conditions under which KEs occur in the AOP (i.e., from chronic high doses and high-dose-rate administration, in the forestomach of rodents-a food storage organ not present in humans) will not exist for human tissues in any real-world exposure conditions.
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